Géraldine Mathonnet

Géraldine Mathonnet

Auto-generated profile, based on publicly available information

Géraldine Mathonnet

Division of Medical Genetics, Sainte Justine Hospital, Montréal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2007 in Science
Verified
Journal Article
Closed access
PDF file
GMGérAldine Mathonnet
GérAldine Mathonnet
MFMarc R. Fabian
Marc R. Fabian
YSYuri V. Svitkin
Yuri V. Svitkin
APArmen Parsyan
Armen Parsyan
LHLaurent Huck
Laurent Huck
NSNahum Sonenberg
Nahum Sonenberg
MicroRNAs (miRNAs) play an important role in gene regulatory networks in animals. Yet, the mechanistic details of their function in translation inhibition or messenger RNA (mRNA) destabilization remain controversial. To directly examine the earliest events in this process, we have developed an in vitro translation system using mouse Krebs-2 ascites cell–free extract that exhibits an authentic miRNA response. We show here that translation initiation, specifically the 5′ cap recognition process, is repressed by endogenous let-7 miRNAs within the first 15 minutes of mRNA exposure to the extract when no destabilization of the transcript is observed. Our results indicate that inhibition of translation initiation is the earliest molecular event effected by miRNAs. Other mechanisms, such as mRNA degradation, may subsequently consolidate mRNA silencing.

1 September 2009 in Molecular Cell
Verified
Journal Article
Closed access
MFMarc R. Fabian
Marc R. Fabian
GMGéraldine Mathonnet
Géraldine Mathonnet
TSThomas Sundermeier
Thomas Sundermeier
HMHansruedi Mathys
Hansruedi Mathys
JZJakob T. Zipprich
Jakob T. Zipprich
NSNahum Sonenberg
Nahum Sonenberg

29 December 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
APArmen Parsyan
Armen Parsyan
DSDavid Shahbazian
David Shahbazian
YMYvan MARTINEAU
Yvan MARTINEAU
EPEmmanuel Petroulakis
Emmanuel Petroulakis
TATommy Alain
Tommy Alain
NSNahum Sonenberg
Nahum Sonenberg
Translational control plays an important role in cell growth and tumorigenesis. Cap-dependent translation initiation of mammalian mRNAs with structured 5′UTRs requires the DExH-box protein, DHX29, in vitro. Here we show that DHX29 is important for translation in vivo. Down-regulation of DHX29 leads to impaired translation, resulting in disassembly of polysomes and accumulation of mRNA-free 80S monomers. DHX29 depletion also impedes cancer cell growth in culture and in xenografts. Thus, DHX29 is a bona fide translation initiation factor that potentially can be exploited as a target to inhibit cancer cell growth.

1 November 2010 in Molecular Cell
Verified
Journal Article
Closed access
EWEdlyn Wu
Edlyn Wu
CTCaroline Thivierge
Caroline Thivierge
MFMathieu Flamand
Mathieu Flamand
GMGeraldine Mathonnet
Geraldine Mathonnet
AVAjay A. Vashisht
Ajay A. Vashisht
TDThomas F. Duchaine
Thomas F. Duchaine

15 April 2011 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
GDG D'AMours
G D'AMours
ZKZ Kibar
Z Kibar
GMG Mathonnet
G Mathonnet
RFR Fetni
R Fetni
FTF Tihy
F Tihy
ELE Lemyre
E Lemyre

25 September 2012 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MSMyriam Srour
Myriam Srour
FHFadi F Hamdan
Fadi F Hamdan
JSJeremy A Schwartzentruber
Jeremy A Schwartzentruber
LPLysanne Patry
Lysanne Patry
LOLuis H Ospina
Luis H Ospina
JMJacques L Michaud
Jacques L Michaud
Background: Joubert syndrome (JBTS) is a predominantly autosomal recessive disorder characterised by a distinctive midhindbrain malformation, oculomotor apraxia, breathing abnormalities and developmental delay. JBTS is genetically heterogeneous, involving genes required for formation and function of non-motile cilia. Here we investigate the genetic basis of JBTS in 12 French–Canadian (FC) individuals. Methods and results: Exome sequencing in all subjects showed that six of them carried rare compound heterozygous mutations in CC2D2A or C5ORF42, known JBTS genes. In addition, three individuals (two families) were compound heterozygous for the same rare mutations in TMEM231(c.12T>A[p.Tyr4*]; c.625G>A[p.Asp209Asn]). All three subjects showed a severe neurological phenotype and variable presence of polydactyly, retinopathy and renal cysts. These mutations were not detected among 385 FC controls. TMEM231 has been previously shown to localise to the ciliary transition zone, and to interact with several JBTS gene products in a complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. siRNA knockdown of TMEM231 was also shown to affect barrier integrity, resulting in a reduction of cilia formation and ciliary localisation of signalling receptors. Conclusions: Our data suggest that mutations in TMEM231 cause JBTS, reinforcing the relationship between this condition and the disruption of the barrier at the ciliary transition zone.